"Western New York Urology Associates is committed to providing compassionate, quality care in a prompt and friendly manner. With our world-class expertise and state-of-the-art technology, we are uniquely qualified to help patients throughout Western New York from Orchard Park, Niagara Falls, NY as well as the Southern Tier and Northern Pennsylvania understand and seek treatment for the urological conditions. Call us today for more information."

During the past decade, Center for Urologic Research of WNY, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Urologic Research of WNY, LLC" #1 sponsor was "Abbott" with 1 trials, followed by "Dong-A PharmTech Co., Ltd." with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "QuatRx Pharmaceuticals Company" with 1 trials sponsored and "Spectrum Pharmaceuticals, Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Urologic Research of WNY, LLC" #1 collaborator was "Hormos Medical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Center for Urologic Research of WNY, LLC" are "Erectile Dysfunction" (2 trials), "Bladder Cancer" (1 trials), "Hypogonadism" (1 trials), "Nocturia" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Center for Urologic Research of WNY, LLC" in a lesser frequency.

Most popular intervention types in "Center for Urologic Research of WNY, LLC" are "Drug" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apaziquone" (1 trials), "DA-8159" (1 trials), "Desmopressin" (1 trials) and "Fispemifene (once daily for 8 weeks)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Urologic Research of WNY, LLC" are 3 trials for "Male" genders, 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Center for Urologic Research of WNY, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Center for Urologic Research of WNY, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Urologic Research of WNY, LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".